The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartis’s labs. The antibody offers the potential to prevent blood clots without the bleeding risks associated with currently available anticoagulants. The post Novartis’s $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots appeared first on MedCity News.
The future of healthcare will be one where technology doesn’t just serve the industry but genuinely improves the lives of individuals, transforming how we interact with medical data, healthcare providers, and our personal well-being. The post Four AI Disruptions in 2025 That Will Reshape Pharma and Healthcare appeared first on MedCity News.
For community hospitals, it’s a sign of the need for a different approach to patient financial communication and payment — one that meets patients where they are and protects their dignity while avoiding undue stress on the organization’s bottom line. The post Plummeting Patient Collection Rates Call for a New Approach to Hospital Payment appeared…
[Sponsored] In an interview, CEO and Founder Chris Crawford talked about the prescription drug cost challenges employers face and how his business can help them save money. The post RxSaveCard Wants to Redesign Pharmacy Benefits to Make Prescription Drugs Cheaper for Employers appeared first on MedCity News.
Dan Liljenquist, Intermountain Health’s chief strategy officer, said that more large health systems should employ a hub-and-spoke model to ensure that rural providers can thrive. Under this model, large health systems partner with rural hospitals — with the rural “spoke” hospitals gaining access to the larger “hub” health system’s technology, staff, medication discounts and more….
Lynx’s Series A round was led by Flare Capital Partners and included participation from CVS Health Ventures, McKesson Ventures, .406 Ventures, Obvious Ventures and Frist Cressey Ventures. The post Lynx Secures $27M To Simplify Healthcare Payments appeared first on MedCity News.
A data safety monitoring board recommended pausing the Phase 2b test of Pliant’s bexotegrast, an experimental treatment for idiopathic pulmonary fibrosis. The move follows a prespecified data review, the company said. The post Pliant Therapeutics Presses Pause on Clinical Trial for Lung Disorder Drug appeared first on MedCity News.
AI can be a highly effective tool for plans aiming to reduce fraud, waste and abuse, but only if it is combined with investigative intelligence. The post AI: A Good Tool to Combat Bad Actors in Healthcare appeared first on MedCity News.
AI-assisted software development can help teams achieve faster delivery, lower costs, and higher-quality results – all key to meeting patients’ and providers’ digital health expectations. The post The Future of Healthcare Apps Depends on AI-Assisted Development appeared first on MedCity News.
CMS recently issued a statement saying that it’s continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be made and what changes they would like to see. The post Could the Trump Administration Change the Medicare Drug Price Negotiation Program? appeared…